Dr. Glazer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 York St
Hunter Buildign
New Haven, CT 06510Phone+1 203-688-1861Fax+1 203-688-1863
Education & Training
- Yale-New Haven Medical CenterResidency, Radiation Oncology, 1988 - 1991
- Yale School of MedicineClass of 1987
Certifications & Licensure
- CT State Medical License 1991 - 2025
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Investigation of the protein corona and biodistribution profile of polymeric nanoparticles for intra-amniotic delivery.Anna Y Lynn, Kwangsoo Shin, David A Eaton, Micky Rose, Xianzhi Zhang
Biomaterials. 2025-03-06 - Tumor-Specific Antigen Delivery for T-cell Therapy via a pH-Sensitive Peptide Conjugate.Annali M Yurkevicz, Yanfeng Liu, Samuel G Katz, Peter M Glazer
Molecular Cancer Therapeutics. 2025-01-02 - Next generation triplex-forming PNAs for site-specific genome editing of the F508del CFTR mutation.Anisha Gupta, Christina Barone, Elias Quijano, Alexandra S Piotrowski-Daspit, J Dinithi Perera
Journal of Cystic Fibrosis. 2025-01-01
Journal Articles
- Krebs-Cycle-Deficient Hereditary Cancer Syndromes Are Defined by Defects in Homologous-Recombination DNA RepairBrian Shuch, Ranjit S Bindra, Christopher D Corso, Peter M Glazer, Nature
- In Utero Nanoparticle Delivery for Site-Specific Genome EditingPeter M. Glazer, Valerie L. Luks, David H. Stitelman, Eric Song, Nature
Press Mentions
- Understanding Radiation Treatments for Cancer with Yale's Dr. Peter GlazerMarch 3rd, 2025
- Yale Advances in Treating Primary Brain Cancers Benefit Patients and ScienceFebruary 11th, 2025
- RefleXion Announces Installation of X1 Platform at Smilow Cancer Hospital at Yale New HavenMarch 1st, 2023
- Join now to see all
Grant Support
- Yale Cancer Biology Training GrantYALE UNIVERSITY2016–2026
- Oncometabolites, DNA Repair, and CancerYALE UNIVERSITY1992–2026
- Oncometabolites, DNA Repair, and CancerYALE UNIVERSITY1992–2026
- Structure-Function Studies of a Cell Penetrating Antibody that Inhibits DNA RepairYALE UNIVERSITY2023–2025
- Novel Triplex-Engineered, Brca1-Mutated Cell Lines For ResearchNational Institute Of Environmental Health Sciences2012
- Epigenetic Regulation In Hypoxic Cancer CellsNational Cancer Institute2010–2012
- Research Programs-Radiobiology And RadiotherapyNational Cancer Institute2007–2011
- Homology- Dependent DNA Repair, Hypoxia, And Cancer TherapyNational Cancer Institute2007–2011
- DNA Repair In Cancer Biology And TherapyNational Cancer Institute2007–2011
- Targeted Correction Of The Human Beta-Globin GeneNational Heart, Lung, And Blood Institute2007–2010
- Cisplatin Damage Response And Cell-To-Cell CommunicationNational Cancer Institute2005–2009
- Research Training: Radiation Therapy, Biology, PhysicsNational Cancer Institute1997–2009
- Targeted Mutagenesis Of DNA VIA Triple Helix FormationNational Cancer Institute1995–2008
- AdministrativeNational Cancer Institute2007
- Recombination Induced By Triple Helix FormationNational Institute Of General Medical Sciences2001–2004
- Genetic Instability Induced By Viral ProteinsNational Cancer Institute1999–2002
- Recombination Induced By Triplex Targeted DNA DamageNational Institute Of General Medical Sciences1997–2000
- Xray Induced MutagenesisNational Institute Of Environmental Health Sciences1997
- Xray Induced Mutagenesis In Transgenic MiceNational Institute Of Environmental Health Sciences1994–1996
- X-RAY Induced Mutagenesis In Transgenic MiceNational Institute Of Environmental Health Sciences1992–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: